CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Gout - Management
What dosing regimen of intramuscular corticosteroid should I use?
- Intramuscular corticosteroids are not specifically licensed for the treatment of gout.
- Triamcinolone acetonide or methylprednisolone can be given as a one-off deep intramuscular injection to relieve the symptoms of gout. In order to avoid the danger of subcutaneous fat atrophy, the corticosteroid should be deeply injected into the gluteal muscle [ABPI Medicines Compendium, 2003; ABPI Medicines Compendium, 2007a].
- The dose depends upon the size of the joint and the severity of the condition.
- For methylprednisolone, doses ranging from 40–120 mg are licensed (although not specifically for use in people with gout).
- For triamcinolone, doses ranging from 40–80 mg are licensed (although not specifically for use in people with gout).
© NHS Institute for Innovation and Improvement